Cargando…

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients

BACKGROUND: Diabetic kidney disease (DKD) patients are facing an extremely high risk of cardiovascular disease (CVD), which is a major cause of death for DKD patients. We aimed to build a deep learning model to predict CVD risk among DKD patients and perform risk stratifying, which could help them p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jingjing, Liu, Dongwei, Li, Guangpu, Duan, Jiayu, Dong, Jiancheng, Liu, Zhangsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263287/ https://www.ncbi.nlm.nih.gov/pubmed/35811691 http://dx.doi.org/10.3389/fcvm.2022.923549

Ejemplares similares

Integrated analysis for treatment scheme of sodium–glucose cotransporter 2 inhibitors in patients with diabetic kidney disease: a real-world study
por: Fang, Li, et al.
Publicado: (2023)

Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy
por: Li, Jia, et al.
Publicado: (2023)

Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus
por: Zhou, Chunyu, et al.
Publicado: (2021)

Serum Total Bilirubin and Progression of Chronic Kidney Disease and Mortality: A Systematic Review and Meta-Analysis
por: Li, Jia, et al.
Publicado: (2021)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy
por: Yan, Qianqian, et al.
Publicado: (2022)

Adults remember their birth weight, an important anamnestic item for cardiovascular and renal disease risk stratification
por: Crivelli-Meyer, Alexandra, et al.
Publicado: (2022)

A Novel Nomogram Based on a Competing Risk Model Predicting Cardiovascular Death Risk in Patients With Chronic Kidney Disease
por: Li, Ning, et al.
Publicado: (2022)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Corrigendum: Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey
por: Duan, Jiayu, et al.
Publicado: (2019)

Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study
por: Luo, Zehao, et al.
Publicado: (2023)

Risk Stratification Model for Predicting Coronary Care Unit Readmission
por: Chen, Tien-Yu, et al.
Publicado: (2022)

Additional prognostic value of stress cardiovascular magnetic resonance for cardiovascular risk stratification after a cryptogenic ischemic stroke
por: Toupin, Solenn, et al.
Publicado: (2022)

A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial
por: Mittas, Nikolaos, et al.
Publicado: (2022)

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
por: Niizuma, Shinichiro, et al.
Publicado: (2017)

The Value of Blood Urea Nitrogen in the Prediction of Risks of Cardiovascular Disease in an Older Population
por: Lan, Qin, et al.
Publicado: (2021)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Research progress of quercetin in cardiovascular disease
por: Zhang, Weiwei, et al.
Publicado: (2023)

Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease
por: Sena, Brena F., et al.
Publicado: (2018)

Using RNA-based therapies to target the kidney in cardiovascular disease
por: Palmer, Trecia C., et al.
Publicado: (2023)

Diabetes Mellitus as a Risk Factor for Progression from Acute Kidney Injury to Acute Kidney Disease: A Specific Prediction Model
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Development and validation of a cardiovascular diseases risk prediction model for Chinese males (CVDMCM)
por: Shan, Ying, et al.
Publicado: (2022)

Multivariate Methods for Genetic Variants Selection and Risk Prediction in Cardiovascular Diseases
por: Malovini, Alberto, et al.
Publicado: (2016)

Editorial: Novel phenotyping and risk stratification strategies for heart failure
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2023)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

Editorial: Risk Stratification Strategies for Cardiac Rhythm Abnormalities
por: Tse, Gary, et al.
Publicado: (2022)

Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study
por: Deng, Yingjian, et al.
Publicado: (2022)

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
por: Wang, Shih-Wei, et al.
Publicado: (2022)

Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)

Machine learning models for predicting the risk factor of carotid plaque in cardiovascular disease
por: Bin, Chengling, et al.
Publicado: (2023)

Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
por: Zhu, Mengmeng, et al.
Publicado: (2022)

The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies
por: Dhindsa, Devinder S., et al.
Publicado: (2018)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
por: Hanssen, Nordin M. J., et al.
Publicado: (2020)

Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes
por: Zhang, Shanshan, et al.
Publicado: (2023)

Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis
por: Yu, Junwen, et al.
Publicado: (2023)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
por: Qin, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h733cnqja9ffid9oe817qduhkv